Showing results (1311-1320 of 1,772) with videos related to
Sort By:
Pageof 178
Immunity|October 19, 2006
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complexXuerong Shi, Lin Leng, Tian Wang, et al.Frontiers in Cardiovascular Medicine|November 21, 2022
Performance of the ABC-bleeding risk score for assessing major bleeding risk in Chinese patients with atrial fibrillation on oral anticoagulation therapy: A real-world studyYu-Feng Wang, Chao Jiang, Liu He, et al.Chemmedchem|March 20, 2014
3-Phenylpropanoic acid-based phosphotyrosine (pTyr) mimetics: hit evolution to a novel orally active protein tyrosine phosphatase 1B (PTP1B) inhibitorYan-Bo Tang, Jun-Zheng Liu, Shu-En Zhang, et al.Orthopaedic Surgery|July 12, 2023
Research Progress on the Pathogenesis of Knee OsteoarthritisXin Du, Zi-Yu Liu, Xing-Xing Tao, et al.Eclinicalmedicine|September 4, 2023
Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022Xingxian Luo, Xin Du, Lin Huang, et al.Biomed Research International|October 15, 2016
Radiation-Guided Peptide Delivery in a Mouse Model of Nasopharyngeal CarcinomaPei-Cheng Lin, Jun-Yan He, Yu-Yin Le, et al.The Journal of Physiology|August 15, 2012
Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's diseaseHelen Kiriazis, Nicole L Jennings, Pamela Davern, et al.Stem Cells (Dayton, Ohio)|October 26, 2024
A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neuronsJasmine L Carter, Julian A N M Halmai, Jennifer J Waldo, et al.Medical Science Monitor Basic Research|May 17, 2013
Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 proteinWei-Xin Du, Bao-Wen Chen, Jin-Biao Lu, et al.The Chinese Journal of Physiology|January 4, 2013
Effects of acute administration of ethanol on experimental arrhythmiaYang Gao, Peng Li, Li-Xia Ma, et al.Pageof 178